Genomatix is a microarray platform which is now licensed by Bayer HealthCare. It enables biologists and bio-informaticians to analyze chip raw data.
It employs the latest genomic annotation.
It combines both literature and pathway mining in a single coherent system. 'After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector.
We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer' states Dr. Martin Seifert, VP Microarray business and collaborative research.